×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SAMRAT PHARMACHEM LTD. | 636.65 | 27.85 | 636.61 | 9.01 | 119.0 | 13.4 |
| PARNAX LAB LTD. | 404.06 | 12.12 | 402.16 | 1.06 | 117 | 10.8 |
| AAREY DRUGS & PHARMACEUTICALS | 1,344.68 | 7.18 | 1,337.89 | 0.26 | 115 | 20.2 |
Samrat Pharmachem Ltd., with Security Code 530125, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 71.1 | 83.9 | 69.1 | 57.4 | 79.7 | 61.6 | 82.6 | 80.8 | 70.1 | 63.6 |
| Expenses | 62.9 | 80.6 | 69.7 | 56.7 | 79.5 | 61.6 | 81.3 | 78.2 | 66.8 | 59.5 |
| Operating Profit | 8.3 | 3.4 | -0.5 | 0.8 | 0.2 | 0.1 | 1.4 | 2.6 | 3.4 | 4.2 |
| OPM % | 11.61% | 4.08% | -0.71% | 1.34% | 0.29% | 0.18% | 1.64% | 3.2% | 4.79% | 6.55% |
| Other Income | 0.2 | 0.1 | 0.0 | 0.4 | 0.3 | 0.4 | 0.3 | 0.6 | 0.5 | 0.0 |
| Interest | 0.2 | 0.6 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Profit before tax | 8.0 | 2.8 | -0.8 | 0.8 | 0.2 | 0.1 | 1.4 | 2.8 | 3.5 | 3.9 |
| Tax % | 26.3% | 24.4% | -5.8% | 18.9% | 179.7% | 144% | 0.4% | 26.7% | 24.4% | 28.8% |
| Net Profit | 5.9 | 2.1 | -0.7 | 0.6 | -0.2 | 0.3 | 1.4 | 2.1 | 2.7 | 2.8 |
| EPS in Rs | 19.14 | 6.78 | -2.41 | 1.98 | -0.61 | 1.11 | 4.52 | 6.68 | 8.61 | 9.01 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 20% |
| 3 Years: | 16% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 7% |
| 3 Years: | -26% |
| TTM: | 44450% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 37% |
| 3 Years: | -4% |
| 1 Year: | 1% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|